Lucarini et al. had previously shown in a mouse model of melanoma that anti-Siglec-F antibody injection was associated with reduced tumoral recruitment of CD8+ effector T-cells, indicating reciprocal promotion of tumor infiltration [18]. The gene discussed is CD8A; the disease is neoplasm.